FDA inspection
Dermolab Pharma Ltd.: FDA inspection ending Oct 13, 2023
FDA inspection 1220238 · Voluntary Action Indicated (VAI) · Sainte-Julie
Key facts
| Inspection ID | 1220238 |
|---|---|
| Firm | Dermolab Pharma Ltd. |
| FEI number | 3003011816 |
| Address | 1421 Nobel St |
| City | Sainte-Julie |
| Country | Canada |
| Fiscal year | 2024 |
| Inspection end date | Oct 13, 2023 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data